BioXcel Therapeutics Stock Options
| BTAI Stock | USD 1.89 0.02 1.05% |
BioXcel Therapeutics' latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 2.99. The BioXcel Therapeutics option chain provides detailed quote and price information for the current BioXcel Therapeutics option contracts. It shows all of BioXcel Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on BioXcel Therapeutics
Analyzing BioXcel Therapeutics' in-the-money options over time can help investors to take a profitable long position in BioXcel Therapeutics regardless of its overall volatility. This is especially true when BioXcel Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money BioXcel Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with BioXcel Therapeutics' stock while costing only a fraction of its price.
BioXcel Therapeutics In The Money Call Balance
When BioXcel Therapeutics' strike price is surpassing the current stock price, the option contract against BioXcel Therapeutics stock is said to be in the money. When it comes to buying BioXcel Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on BioXcel Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
BioXcel Current Options Market Mood
BioXcel Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps BioXcel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most BioXcel Therapeutics' options investors are not very successful. BioXcel Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current BioXcel contract
Base on the Rule 16, the options market is currently suggesting that BioXcel Therapeutics will have an average daily up or down price movement of about 0.19% per day over the life of the 2025-08-15 option contract. With BioXcel Therapeutics trading at USD 1.89, that is roughly USD 0.003532. If you think that the market is fully incorporating BioXcel Therapeutics' daily price movement you should consider buying BioXcel Therapeutics options at the current volatility level of 2.99%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing BioXcel Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" BioXcel calls. Remember, the seller must deliver BioXcel Therapeutics stock to the call owner when a call is exercised.
BioXcel Therapeutics Option Chain
When BioXcel Therapeutics' strike price is surpassing the current stock price, the option contract against BioXcel Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
BioXcel Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on BioXcel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for BioXcel. It also shows strike prices and maturity days for a BioXcel Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BTAI250815C00004000 | 0 | 4.0 | 0.0 - 0.2 | 0.2 | |
Call | BTAI250815C00003000 | 0 | 3.0 | 0.0 - 0.2 | 0.2 | |
Call | BTAI250815C00002000 | 41 | 2.0 | 0.0 - 0.2 | 0.09 | Out |
Call | BTAI250815C00001000 | 1 | 1.0 | 0.0 - 0.75 | 0.75 | In |
Put | BTAI250815P00004000 | 0 | 4.0 | 3.3 - 4.0 | 3.3 | In |
Put | BTAI250815P00003000 | 0 | 3.0 | 2.2 - 3.0 | 2.2 | In |
Put | BTAI250815P00002000 | 0 | 2.0 | 1.5 - 2.0 | 1.5 | In |
Put | BTAI250815P00001000 | 0 | 1.0 | 0.5 - 1.0 | 0.5 |
BioXcel Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
BioXcel Total Stockholder Equity
Total Stockholder Equity |
|
BioXcel Therapeutics Corporate Management
| Javier JD | Chief VP | Profile | |
| Frank Yocca | Chief Scientific Officer | Profile | |
| Mary Coleman | VP Relations | Profile | |
| Javier Rodriguez | Chief VP | Profile | |
| Cedric Burg | VP Management | Profile | |
| Robert Scala | Vice Planning | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioXcel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in BioXcel Stock please use our How to Invest in BioXcel Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioXcel Therapeutics. If investors know BioXcel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioXcel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.12) | Revenue Per Share | Quarterly Revenue Growth (0.71) | Return On Assets | Return On Equity |
The market value of BioXcel Therapeutics is measured differently than its book value, which is the value of BioXcel that is recorded on the company's balance sheet. Investors also form their own opinion of BioXcel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is BioXcel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioXcel Therapeutics' market value can be influenced by many factors that don't directly affect BioXcel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioXcel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioXcel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioXcel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.